Cervical Degenerative Disc DiseaseNCT06383962
Post-Market Data Collection to Evaluate the Performance of the Synergy Disc®
An observational study of Cervical Degenerative Disc Disease, run by Synergy Spine Solutions at 2 sites in United Kingdom.
Trial summary
This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease. Read more about this study
- Who is it for?
- Ages 21 years and older
- Conditions the study is for
- Cervical Degenerative Disc Disease
- What is being tested?
- Synergy cervical spine disc replacement
- Type of treatment
- Medical device
- How many people
- 50 participants
- Where
- 2 sitesUnited Kingdom
- Study dates
- 17 Mar 2025to Dec 2034
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- Adult, Older adult
Study population: Patients who have had (retrospective cohort) or who are going to (prospective cohort) the Synergy cervical disc and have cervical degenerative disc disease that has been unresponsive to conservative treatment.
Who may be able to join
- Age 21 or above at the time of the surgery. Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
- Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression:
- herniated disc and/or osteophyte formation Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.) Failed a minimum of 6 weeks conservative treatment Written informed consent given by subject.
Who cannot join
- Exclusion Criteria: All answers must be NO to be eligible for the study. Moderate to advanced spondylosis Diagnosis of osteoporosis Active systemic infection or infection at the operative site Pregnancy Marked cervical instability on lateral, coronal, or flexion/extension radiographs Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level Severe pathology of the facet joints of the involved vertebral bodies Previous diagnosis of osteopenia or osteomalacia More than one immobile vertebral level between C1 and T1 from any cause Morbid obesity Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)
Trial locations and contacts
2 sites in 1 country. Contact the study team or a site near you to ask about taking part.
United Kingdom2 sites, 2 recruiting
- Recruiting
Royal Orthopaedic Hospital
Birmingham
Sam Papadopoullos, sam.papadopoullos@nhs.net
Timothy Knight, MD
- Recruiting
Kings College Hospital
London
Sarah Hatch, sarah.hatch3@nhs.net
Gordan Grahovac, MD
About this study
Official title: A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc®
This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.
- Conditions
- Cervical Degenerative Disc Disease
- Being tested
- Synergy cervical spine disc replacement
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Synergy cervical spine disc replacementDevice
motion preservation disc
| Study group | Role | What they receive |
|---|---|---|
| Prospective | All patients for whom the decision has been made to have the Synergy Disc system implanted and give informed consent will be enrolled in this study, following country-specific requirements. Receives: Device: Synergy cervical spine disc replacement | |
| Retrospective | Patients who have previously received the Synergy Disc system in the last ten years are eligible for inclusion in the retrospective data collection; a waiver of consent, or an informed consent, for the retrospective data collection from the medical records of the implanting surgeon will be sought per country-specific regulations. Receives: Device: Synergy cervical spine disc replacement |
What is being measured
The primary outcome is the main question the study is designed to answer.
Neck Disability Index (NDI)
Neck disability Index improvement of >15 pts (out of 100) in subjects by 12 months post operative compared with baseline. A lower score is a better score.
Measured: 12 months
Device Related or Device Procedure Related Adverse Events
Absence of major device related adverse events defined as radiographic failure, neurologic failure or failure by adverse event
Measured: 12 months
Secondary outcomes (5)
Neck and Arm Pain Measurement
Pain will evaluated by the Visual analog scale (VAS) (place a line from zero where there is no pain to 10 which is the worst pain imaginable), by NRS (circle a number from zero to ten where zero equals no pain and ten is worst imaginable) to or a verbal description that the doctor writes down, per the site's Standard of Care. A change of at least 20 mm will be considered clinically significant. Neck pain as measured on a 100mm VAS at baseline and at each follow-up timepoint. Left and Right arm/shoulder pain as measured on a 100 mm VAS at baseline and at each follow up time-point.
Measured: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Patient Satisfaction
patient completed questionnaire on their satisfaction with the disc replacement surgery
Measured: 6 week, 3 month, 6 month, 12 month, 24 month
Motor and Sensory Function in the Arm
maintenance or improvement in neurologic status compared with baseline will be assessed using a defined numeric scale ranging from 0 (normal) to 5 (deficit)
Measured: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Nurick's Criteria
Disease status as characterized by physician at each time point
Measured: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Odom's criteria
surgical outcome characterized by physician at each post operative visit
Measured: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted25 Apr 2024
- Study start17 Mar 2025
- Primary completionDec 2029 (estimated)
- Study completionDec 2034 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cervical Degenerative Disc DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Synergy Spine Solutions
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- MCRA
- Responsible party
- Sponsor
- Investigators
- Robyn Capobianco, PhD, Study director, Synergy Spine Solutions
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06383962
- Sponsor's protocol ID
- CP 21-001-UK02
- Status last verified
- Apr 2026
- First submitted
- 22 Apr 2024
- Last updated
- 1 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 1 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Single Site Post-Market Data Collection Protocol to Evaluate the Performance of Synergy Spine Solutions Synergy Disc®
- ClinicalTrials.gov ID
- NCT06383962
- Acronym / sponsor ID
- CP 21-001-UK02
- Conditions
- Cervical Degenerative Disc Disease
- Study type
- Observational
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Synergy Spine SolutionsIndustry (pharma, biotech, devices)
- Collaborators
- MCRA
- Study start
- 17 Mar 2025 (actual)
- Primary completion
- Dec 2029 (estimated)
- Study completion
- Dec 2034 (estimated)
- First posted
- 25 Apr 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This is a real world data collection observational study at a single site. There are both prospective and retrospective cohorts. The study will examine the safety and effectiveness of the Synergy cervical disc system in patients with degenerative cervical disc disease.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Prospective | – | Device: Synergy cervical spine disc replacementAll patients for whom the decision has been made to have the Synergy Disc system implanted and give informed consent will be enrolled in this study, following country-specific requirements. |
| Retrospective | – | Device: Synergy cervical spine disc replacementPatients who have previously received the Synergy Disc system in the last ten years are eligible for inclusion in the retrospective data collection; a waiver of consent, or an informed consent, for the retrospective data collection from the medical records of the implanting surgeon will be sought per country-specific regulations. |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- Patients who have had (retrospective cohort) or who are going to (prospective cohort) the Synergy cervical disc and have cervical degenerative disc disease that has been unresponsive to conservative treatment.
Key inclusion criteria (3 listed)
- Age 21 or above at the time of the surgery. Have had (retrospective cohort) or the decision has been made to have (prospective cohort) the Synergy Disc implanted Skeletally mature patients for reconstruction of the disc from C3-C7 following a single or multiple level discectomy for intractable radiculopathy
- Intractable radiculopathy and/or myelopathy with at least one of the following producing symptomatic nerve root and/or spinal cord compression:
- herniated disc and/or osteophyte formation Symptomatic nerve root and/or spinal cord compression documented by patient history (arm or neck pain and/or neurologic deficit) and imaging (CT, MRI, x-rays, etc.) Failed a minimum of 6 weeks conservative treatment Written informed consent given by subject.
Key exclusion criteria (1 listed)
- Exclusion Criteria: All answers must be NO to be eligible for the study. Moderate to advanced spondylosis Diagnosis of osteoporosis Active systemic infection or infection at the operative site Pregnancy Marked cervical instability on lateral, coronal, or flexion/extension radiographs Cervical spine condition other than symptomatic cervical disc disease requiring surgical treatment at the involved level Severe pathology of the facet joints of the involved vertebral bodies Previous diagnosis of osteopenia or osteomalacia More than one immobile vertebral level between C1 and T1 from any cause Morbid obesity Vulnerable person (pregnant patients, emergency cases, children, prisoners and people without mental capacity)
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Synergy cervical spine disc replacementmotion preservation disc | Device | Prospective, Retrospective |
Primary outcome
Neck Disability Index (NDI)
Time frame: 12 months
Neck disability Index improvement of >15 pts (out of 100) in subjects by 12 months post operative compared with baseline. A lower score is a better score.
Device Related or Device Procedure Related Adverse Events
Time frame: 12 months
Absence of major device related adverse events defined as radiographic failure, neurologic failure or failure by adverse event
5 secondary outcomes
Neck and Arm Pain Measurement
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Patient Satisfaction
Time frame: 6 week, 3 month, 6 month, 12 month, 24 month
Motor and Sensory Function in the Arm
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Nurick's Criteria
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Odom's criteria
Time frame: pre-operative, 6 week, 3 month, 6 month, 12 month, 24 month
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 1 May 2026.
- Individual participant dataSharing planned: No
Related trials for Cervical Degenerative Disc Disease
Active, not recruiting
The Synergy Disc for the Treatment of 2 Level Cervical Degenerative Disc Disease Compared With Cervical Fusion Surgery
Cervical Degenerative Disc Disease
Enrolling by invitation
Assessing Microbiome in Primary Anterior Cervical Fusion Patients
Cervical Stenosis, Myelopathy
Active, not recruiting
Anterior Cervical Disectomy And Fusion Using The Tritanium® C Anterior Cervical Cage For One Or Two-Levels
Cervical Disc Herniation, Cervical Disc Degeneration
RecruitingObservational study
PMCF Study Fortilink-SC
Degenerative Disc Disease in Cervical Spine, Stenosis Cervical Spine
Enrolling by invitation
Physiotherapy and Osteopathic Treatment for Pain in the Cervical and Lumbar Spine and Temporomandibular Joints
Disc Degenerative Disease, Spine Degeneration
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Robyn Capobianco, PhD study director
Synergy Spine Solutions
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cervical Degenerative Disc Disease, run by Synergy Spine Solutions at 2 sites in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 1 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Robyn Capobianco, PhD ((720) 787-9063, rcapobianco@synergyspinesolutions.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Neck Disability Index (NDI) (time frame: 12 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 May 2026.